Serum pTau181/Neurofilament Light Elevations Correlate with Opioid Use and Fecundity in a Psychiatric Clinic
2024

Serum pTau181 and Neurofilament Light Elevations Correlate with Opioid Use and Fecundity

Sample size: 73 publication Evidence: moderate

Author Information

Author(s): Emily Hanson, Karl Berner, Jon Berner

Primary Institution: Woodinville Psychiatric Associates

Hypothesis

The study investigates the relationship between serum tau and neurofilament light levels with opioid use and fecundity in a psychiatric clinic.

Conclusion

The study found that tau levels are associated with opioid use and increased fecundity, while amyloid levels are associated with decreased fecundity.

Supporting Evidence

  • Tau associates with opioid use and increased fecundity.
  • Adverse amyloid ratio associates with decreased fecundity.
  • Previous studies documented elevated pTau181 and TNFa in patients with pain.

Takeaway

This study looked at how certain brain markers relate to pain medication use and having children, finding that one marker is linked to both.

Methodology

Chart review of an initial cohort screening for dementia risk.

Participant Demographics

Participants were from a psychiatric clinic.

Statistical Information

P-Value

p=0.01 for tau and opioid use; p=0.079 for tau and fecundity; p=0.067 for amyloid and fecundity.

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1093/geroni/igae098.3712

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication